Combat Disorders Clinical Trial
Official title:
Reintegration: The Role of Spouse Telephone BATTLEMIND Pilot Study
Verified date | June 2013 |
Source | Memphis VA Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Federal Government |
Study type | Interventional |
This study will expand the Department of Defense (DoD) one time, face-to-face post deployment BATTLEMIND training for spouses of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Guard/Reserve service members into year-long, telephone groups focusing on education, skills building and support. The goal is to build spouses' resilience to cope with reintegration, help them serve as a support system for returning service members, and ease the transition for families post-deployment.
Status | Completed |
Enrollment | 86 |
Est. completion date | November 2011 |
Est. primary completion date | July 2011 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: 1. have a spouse who participated in OEF/OIF and is at least 1 month post-deployment; 2. if not married, must have lived as married for at least one year; 3. live with the service member when not deployed; 4. have been a spouse/significant other throughout the service member's deployment period; 5. and have a telephone. Exclusion Criteria: 1. current diagnosis of schizophrenia or other major mental illness; 2. auditory impairment that would make telephone use difficult; or 3. service member refusal of assent for spouse to participate. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United States | Memphis VA Medical Center | Memphis | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Memphis VA Medical Center | United States Department of Defense |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Spouse Self-report of Depression | Depression measured with the Patient Health Questionnaire (PHQ)-9 at baseline, six and 12 months. Scores range from 0-27 with lower scores indicating less depressive symptoms. | Baseline, 6 months, and 12 months | Yes |
Primary | Anxiety | Anxiety measured with the Generalized Anxiety Disorder -7 (GAD-7)measured at baseline, six and 12 months. Scores range from 0-21, with lower scores indicating fewer anxiety symptoms. | baseline, 6 months and 12 months | No |
Primary | Quality of Marriage | Measure of marriage quality using Quality Marriage Index at baseline, six and 12 months. Scores range from 6-45 with higher scores indicating better quality of marriage. | Baseline, 6 and 12 months | No |
Secondary | Family Coping | Family problem solving measured at baseline, six and 12 months with the F-COPES measure. Scores range from 29-145 with higher scores indicating better coping. | Baseline, 6 months and 12 months | No |
Secondary | Spouse Social Support | Support measured with the Social Support Index at baseline, six and 12 months. Scores range from 0-68 with higher scores indicating better social support. | baseline, 6 months, and 12 months | No |
Secondary | Family Communication | Family communication measured with the Family Problem Solving Communication scale at baseline, six and 12 months. Scores range from 0-30 with higher scores indicating better communication. | baseline, 6 months, and 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00990106 -
Augmentation Trial of Prazosin for Post-Traumatic Stress Disorder (PTSD)
|
N/A | |
Completed |
NCT00419029 -
Motivational Interviewing to Engage Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans in Mental Health Treatment
|
N/A | |
Terminated |
NCT03736356 -
Long-term Health Outcomes of AE Casualties
|
||
Completed |
NCT00371176 -
A Placebo-Controlled Trial of D-Cycloserine and Exposure Therapy for Combat-PTSD
|
N/A | |
Completed |
NCT02809326 -
Trauma Management Therapy for OEF and OIF Combat Veterans
|
Phase 2 | |
Active, not recruiting |
NCT01216982 -
Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders
|
Phase 2 | |
Completed |
NCT01049516 -
Prolonged Exposure for Post Traumatic Stress Disorder (PTSD) Among Operation Iraqi Freedom/Operation Enduring Freedom (OIF/OEF) Personnel
|
N/A | |
Completed |
NCT03934658 -
Remote Study of NightWare for PTSD With Nightmares
|
N/A | |
Completed |
NCT02556645 -
A Comparison of Web-Prolonged Exposure (Web-PE) and Present-Centered Therapy (PCT) for PTSD Among Active-Duty Military Personnel
|
N/A | |
Completed |
NCT00539279 -
Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder
|
N/A | |
Completed |
NCT00974402 -
Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings
|
N/A | |
Enrolling by invitation |
NCT04040387 -
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
|
N/A | |
Active, not recruiting |
NCT02825602 -
Vietnam Era Health Retrospective Observational Study
|
||
Completed |
NCT02266329 -
Chronic Postconcussive Headache: A Placebo-Controlled Treatment Trial of Prazosin
|
Phase 1/Phase 2 | |
Completed |
NCT02226367 -
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
|
N/A | |
Terminated |
NCT01062022 -
FOCUS-CI: A Preventive Intervention With Children and Families of the Combat Injured
|
N/A | |
Completed |
NCT00475241 -
Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms
|
Phase 2/Phase 3 | |
Completed |
NCT00292370 -
Quetiapine Augmentation for Treatment-resistant PTSD
|
Phase 4 | |
Completed |
NCT03795987 -
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
|
N/A | |
Completed |
NCT03337750 -
An Open-Trial of Web-Prolonged Exposure (Web-PE) Among Active-Duty Military
|
N/A |